ClinicalTrials.govpublic full text
Axitinib With or Without Anti-OX40 Antibody PF-04518600 in Treating Patients With Metastatic Kidney Cancer
clear cell renal cell carcinoma, metastatic renal cell cancer, recurrent renal cell carcinoma, stage iv renal cell cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 992545
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.